GeneDx Holdings Corp.
NASDAQ: WGSWW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Katherine A. Stueland
- Employees
- 1,000
- Headquarters
- Stamford, United States
- IPO year
- 2021
- Market cap
- $1.8B
- Website
- https://www.genedx.com
Loading WGSWW…
Loading profile data…Frequently asked questions about WGSWW
What does GeneDx Holdings Corp. (WGSWW) do?
GeneDx Holdings Corp., through its various operational units, specializes in delivering genomics-driven diagnostic and informational solutions. Central to its services is Centrellis, an advanced health intelligence platform powered by artificial intelligence. This platform effectively merges digital technologies with AI capabilities, enabling re...
Where does WGSWW trade?
GeneDx Holdings Corp. (WGSWW) trades on the NASDAQ Global Select.
What sector is WGSWW in?
GeneDx Holdings Corp. (WGSWW) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of GeneDx Holdings Corp.?
Katherine A. Stueland is the chief executive officer of GeneDx Holdings Corp. (WGSWW).
Where is GeneDx Holdings Corp. headquartered?
GeneDx Holdings Corp. is headquartered in United States.
Does WGSWW pay a dividend?
GeneDx Holdings Corp. (WGSWW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WGSWW go public?
GeneDx Holdings Corp. (WGSWW) completed its initial public offering in 2021.